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Abstract
Background: Goblet cell metaplasia that causes mucus hypersecretion and obstruction in the airway lumen could be life
threatening in asthma and chronic obstructive pulmonary disease patients. Inflammatory cytokines such as IL-13 mediate
the transformation of airway ciliary epithelial cells to mucin-secreting goblet cells in acute as well as chronic airway
inflammatory diseases. However, no effective and specific pharmacologic treatment is currently available. Here, we
investigated the mechanisms by which aldose reductase (AR) regulates the mucus cell metaplasia in vitro and in vivo.
Methodology/Findings: Metaplasia in primary human small airway epithelial cells (SAEC) was induced by a Th2 cytokine, IL-
13, without or with AR inhibitor, fidarestat. After 48 h of incubation with IL-13 a large number of SAEC were transformed
into goblet cells as determined by periodic acid-schiff (PAS)-staining and immunohistochemistry using antibodies against
Mucin5AC. Further, IL-13 significantly increased the expression of Mucin5AC at mRNA and protein levels. These changes
were significantly prevented by treatment of the SAEC with AR inhibitor. AR inhibition also decreased IL-13-induced
expression of Muc5AC, Muc5B, and SPDEF, and phosphorylation of JAK-1, ERK1/2 and STAT-6. In a mouse model of ragweed
pollen extract (RWE)-induced allergic asthma treatment with fidarestat prevented the expression of IL-13, phosphorylation
of STAT-6 and transformation of epithelial cells to goblet cells in the lung. Additionally, while the AR-null mice were
resistant, wild-type mice showed goblet cell metaplasia after challenge with RWE.
Conclusions: The results show that exposure of SAEC to IL-13 caused goblet cell metaplasia, which was significantly
prevented by AR inhibition. Administration of fidarestat to mice prevented RWE-induced goblet cell metaplasia and AR null
mice were largely resistant to allergen induced changes in the lung. Thus our results indicate that AR inhibitors such as
fidarestat could be developed as therapeutic agents to prevent goblet cell metaplasia in asthma and related pathologies.
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Introduction
In sensitized individuals, exposure to environmental allergens
(such as pollens, molds, dust mites) induce inflammatory response
in the airway characterized by inappropriate Th2 response [1,2],
such as secretion of cytokines, especially Th2 type [3,4]. The
altered cytokine levels and subsequent changes in airway redox
status lead to goblet cell metaplasia, transforming airway epithelial
cells into mucus secreting cells, which release overwhelming
amounts of mucin, especially mucin5AC, which obstructs the
smaller alveoli and causes obstruction in breathing in asthma [5–
10]. Excessive mucus secretion often becomes life threatening [11].
Since oxidative stress exacerbates pathological changes in the
airway including goblet cells metaplasia and hyperplasia leading to
mucin hypersecretion [12–14], blocking the oxidative stress-
induced signaling should be effective in decreasing mucin
production and airway obstruction in asthma.
Th2 cytokines, especially IL-4 and IL-13, induce the phosphor-
ylation of STAT (signal transducer and activator of transcription) -
6 which transcribes genes involved in metaplasia leading to
excessive mucus production [5,15–19]. Recently, SPDEF (SAM-
pointed domain–containing ETS transcription factor), a member
of the Ets family of transcription factors, has been implicated in
goblet cell metaplasia in response to allergen or IL-13 challenge
[20]. Park et al (2007) have indeed, demonstrated increased goblet
cell differentiation in SPDEF transgenic mice in the respiratory
epithelium [21]. Studies have also demonstrated the role of STAT-
6 and SPDEF in airway inflammation and resultant mucin
production [22–25]. Since cytokines and growth factors are known
to generate ROS which act as secondary messenger, and AR has
been implicated in ROS-mediated inflammation resulting in the
lung pathology [26,27]. Our hypothesis is that inhibition of AR
should ameliorate the ROS-induced inflammatory signals in the
airway and thereby decrease/block the inflammation and resultant
pathological outcomes.
We have recently demonstrated that sensitization and challenge
of mice with RWE resulted in increased expression of Th2
cytokines such as IL-4, IL-5 and IL-13 in the lung. Also a large
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lavage. Inhibition of AR significantly decreased these changes
indicating that AR could be crucial in the allergen-induced airway
inflammation [26]. However the exact role of AR in goblet cell
metaplasia in allergic asthma is not clear. We have previously
shown that AR catalyzes the reduction of lipid-aldehydes and their
glutathione conjugates, formed inside the cells during oxidative
stress. The reduced GS-lipid aldehyde conjugates activate up-
stream kinases resulting in the activation of transcription factors
and subsequent expression of inflammatory genes [28–32]; [Fig. 1].
Recently, Mandal et al (2010) demonstrated that IL-13 stimulates
ROS synthesis in intestinal epithelial cells which in turn positively
regulates phosphorylation of ERK1/2 and STAT6 and also
stimulates expression of NADPH oxidase [33]. Studies have
demonstrated that oxidative stress induces AR which in turn
mediates JAK-STAT signaling in the pathophysiology of myocar-
dial ischemic injury [34,35]. Since IL-13-induced STAT-6
activation is implicated in the goblet cell metaplasia, we
hypothesized that allergen-induced IL-13 production in allergic
asthma would result in the exacerbated oxidative stress that would
cause increase in AR in the airway cells leading to altered cellular
signaling that induce transformation of epithelial cells into goblet
cells. Therefore, we investigated the role of AR in Th2 cytokine,
IL-13 -mediated activation of STAT-6 signaling that is known to
cause goblet cell metaplasia and enhanced mucus production in
the airway [19,23]. We used cultured primary airway epithelial
cells grown on the air-liquid interface (ALI) and RWE-induced
murine model of allergic asthma. To delineate the role of AR in
metaplasia of airway epithelial cells we used a specific inhibitor of
AR, fidarestat which has already undergone 52 weeks of phase III
clinical trial for diabetic neuropathy and was found to have no
irreversible side effects. Our results demonstrated that AR
inhibition significantly prevented development of goblet cell
metaplasia induced by IL-13 in human airway epithelial cells
and by allergen (RWE) in mice.
Results
AR inhibition prevents IL-13 –induced ROS levels in SAEC
Since cytokines- induced oxidative stress is known to mediate
molecular signaling that leads to differentiation of airway epithelial
cells into mucus cells, so we determined the effects of AR
inhibition on IL-13-induced ROS levels in SAEC by two different
methods. As shown in Fig. 2A and 2B, stimulation with IL-13
caused approximately two-fold increase in the ROS levels over the
control and treatment of the cells with fidarestat significantly
(80%) prevented the increase. These results suggest that cytokine-
induced oxidative stress could be prevented by inhibition of AR.
AR inhibition prevents IL-13-induced goblet cell
metaplasia in SAEC
To investigate the role of AR in the regulation of goblet cells
metaplasia and mucin production, we used an air-liquid interface
culture system that mimics in-vivo airway environment. First, we
cultured primary human airway epithelial cells on polyethylene
terephthalate (PET) membrane insert with collagen type-1 coating.
The cells on the collagen-coated membrane insert formed a
consistent 2–3 cells thick layer of airway cells. Further, the
monolayer cells fully differentiated into ciliated cells when cultured
on the ALI in EGF-containing medium for 11 days (Fig. 3A;
control) and when these cells were stimulated with IL-13 for 48 h,
the number of ciliated cells were markedly reduced as also
determined by immunostaining using b-tubulin specific antibodies.
However, AR inhibition by fidarestat preserved the ciliated
morphology (Fig. 3B). AR inhibitor alone had no toxic effects
and the monolayers of ciliated cells were largely intact. As
determined by PAS staining a large number of ciliated cells (,6-
fold) transformed into mucus-laden goblet cells when stimulated
with IL-13 for 48 h, whereas addition of AR inhibitor, fidarestat,
in the medium prior to IL-13 challenge prevented the airway cells
from differentiating into goblet cells (data not shown).
AR inhibition prevents IL-13-induced expression of Mucin
and SPDEF in airway epithelial monolayer
Next, we stained sections of monolayer cells with antibodies
against Muc5AC. As shown in Fig. 4A and 4B, IL-13 stimulation
resulted in a large number of Muc5AC immuno-positive cells.
Figure 1. Prevention of redox signaling by AR inhibition.
Stimulation with Ragweed pollens, allergens, growth factors, or
cytokines cause increased ROS production inside the cells. The ROS
could oxidize membrane lipids to form lipid aldehydes such as 4-
hydroxynonenal (HNE), which readily reacts with glutathione and form
GS-conjugates such as GS-HNE. AR catalyzes the reduction of GS-HNE
into GS-DHN. The latter is known to activate various downstream
protein kinases such as PKC, PI3K and MAPK activating transcription
factors NF-kB and AP-1 which transcribe various inflammatory markers,
including IL-13 which in paracrine fashion induces more ROS formation.
The GS-DHN could also phosphorylate JAK-1 and MAPK such as ERK1/2,
eventually phosphorylating and activating STAT-6 which translocate to
the nucleus and transcribe genes including mucin genes leading to
goblet cell metaplasia. The continuously formed GSDHN may amplify
the signaling loop by increased ROS production via PKC/NOX pathway.
Inhibition of AR blocks the initial as well as the amplification loop and
prevents ROS-induced pathological changes [Ref. 31,32].
doi:10.1371/journal.pone.0014440.g001
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IL-13, the number of cells with Muc5AC positive staining
decreased significantly (,70%) suggesting that only a few cells
had transformed into goblet cells. Next, we measured the level of
secreted Muc5AC in the culture medium using an ELISA. There
was a marked increase in the secretion of Muc5AC in the medium
after IL-13 stimulation which was significantly (,80%) prevented
by treatment with AR inhibitor (Fig. 4C). These results suggest
that AR regulates IL-13-mediated metaplasia and mucus produc-
tion in the airway epithelial cells and inhibition of AR could
prevent these events. Next, we examined whether Mucin levels in
these cells were regulated by transcription or translation. As shown
in Fig. 5A, upper panel, Muc5AC-specific RNA expression
increased by approximately 3-fold in IL-13-treated SAEC
monolayer and fidarestat significantly prevented the increase.
A number of studies have shown that SPDEF regulates the
expression of several genes in the airway epithelial cells including
both acidic and neutral mucins and cause goblet cell hyperplasia
[20,21]. We therefore, determined the expression of SPDEF
mRNA levels by RT-PCR in our cell-culture model and observed
that IL-13 significantly enhanced the expression of SPDEF in
epithelial cells, whereas control cells had only basal level of
expression. When these cells were treated with AR inhibitor prior
to IL-13 stimulus, the SPDEF mRNA levels decreased significantly
(Fig. 5A, lower panel).
Next we measured the levels of Muc5AC and Muc5B proteins by
immunoblotting in SAEC monolayer after incubation with IL-13
for 24 and 48 h. Muc5AC/B were not detectable after 24 h
however, after 48 h of incubation with IL-13 there was a robust
increase in the expression of protein levels (Fig. 5B, top two panels),
which was significantly (,75 and ,50%, respectively) prevented in
fidarestat treated cells. Also in the airway epithelial cell monolayer
incubated with IL-13, the levels of SPDEF protein in the cells
significantly increased after 24 h and further increased after 48 h
and the increase was significantly (,50%) prevented by AR
inhibitor treated cells (Fig. 5B). The decrease in the levels of protein
corresponded with the decrease in mRNA levels of SPDEF and
Muc5AC/B suggesting that SPDEF and Muc5AC genes are
induced in the presence of IL-13, and that the expression of
Muc5AC is prevented by AR inhibition at the level of transcription.
AR inhibition prevents IL-13-induced phosphorylation
and activation of signaling intermediates
Since AR inhibition in airway epithelial cells monolayer on ALI
successfully prevented the expression of transcription regulator
SPDEF and subsequent expression of mucin, we next investigated
the effect of AR inhibition on the molecular mechanism(s) that
regulates the expression of these mediators of asthma. We
stimulated the cells grown on ALI with IL-13 in presence or
absence AR inhibitor and determined thephosphorylationofJAK1,
ERK1/2 and STAT-6 proteins. As shown in Fig. 6, IL-13 caused a
time-dependent increase in the phosphorylation of STAT-6 and
upstream mediators such as JAK1 and ERK1/2. When these cells
were treated with AR inhibitor prior to IL-13 stimulus, the
phosphorylation of these proteins decreased significantly. Further,
in cells treated with AR inhibitor alone the basal phosphorylation of
Figure 2. Inhibition of AR prevents IL-13-induced ROS production in SAEC. (A) Approximately 5610
4 cells were seeded on 2-chambered
slides and starved in serum-free basal medium without or with fidarestat for overnight. The cells were washed with 16HBSS and incubated with
10 mMH 2DCF-DA at 37uC for 30 min, washed again and treated with IL-13 (25 ng/ml) for 1 h. The cells were washed with cold 16HBSS twice and
mounted using floursave mounting medium with DAPI. Photomicrographs were acquired using a fluorescence microscope (Nikon). A representative
image is shown (n=4); Magnification 4006.( B) Approximately 10,000 SAEC were plated per well in a 96-well plate and serum-starved for 24 h
without or with fidarestat. The cells were washed with 16HBSS and incubated with 10 mMH 2DCF-DA at 37uC for 30 min. Cells were washed again to
remove excess H2DCF-DA and treated with Il-13 (25 ng/ml) in basal media for 1 h. At the end of the treatment, cells were washed twice with HBSS
and fluorescence was determined at 485 nm excitation and 538 nm emission wavelengths. Relative ROS production is expressed as mean
fluorescence intensity (MFI) (arbitrary units). The bars represent mean 6 SD (n=4–6); (
*p,0.01 vs. Control;
**p,0.05 vs. IL-13).
doi:10.1371/journal.pone.0014440.g002
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suggest that AR regulates the activation of key signaling
intermediates involved in goblet cell metaplasia which transforms
airway-ciliated epithelial cells to mucus secreting goblet cells.
AR inhibition prevents RWE-induced expression of IL-13
and activation of STAT-6 in mouse lung
Since Th2 cytokines, especially IL-13, is involved in the goblet
cell metaplasia, we examined the expression levels of IL-13 in mice
lung after RWE challenge and found that its level increased
approximately 6-fold compared to control and treatment with
fidarestat prior to challenge prevented this increase (Fig. 7). To
examine whether increased IL-13 levels coincided with the
phosphorylation and activation of STAT-6 which play a major
role in metaplasia, we killed the mice after 20 h of RWE challenge
and performed immunofluorescence studies on the lung section
using phospho-STAT-6 antibodies. We observed that while the
lungs of control mice showed only background, RWE-challenged
mice lung epithelium showed a marked increased in the
fluorescence intensity specific to phospho-STAT-6, which was
prevented by AR inhibition (Fig. 8A). We confirmed our results by
DAB-based immunohistochemistry on the lung sections as well
(Fig. 8B). These results suggest that inhibition of AR could prevent
the allergen-induced IL-13 expression and subsequent activation
of STAT-6 in vivo.
AR inhibition/deficiency prevents RWE-induced goblet
cell metaplasia in mice lung
We next examined the effect of AR inhibition on goblet cell
metaplasia in RWE-sensitized and-challenged mice. After 72 h of
Figure 3. AR inhibition prevents IL-13-induced loss of cilia and b-tubulin in airway epithelial cell monolayer. Approximately 8.5610
4
SAEC were seeded per 12 mm diameter PET transparent insert and cultured for 7 days in differentiation media supplied from both lower and upper
sides followed by culture on ALI for 11 days for differentiation into ciliated cells. The monolayer was treated with AR inhibitor for overnight and
stimulated with IL-13 for 48 h. The monolayers on the membrane inserts were fixed for 24 h in z-fix (10% buffered formalin with zinc) at 4uC, paraffin
embedded and 5 mM sections were cut. (A) The H&E stained sections were examined under the light microscope; magnification 4006. Inset shows
magnified view of the selected regions from each representative photomicrograph (n=4). (B) Immunohistochemistry using b-tubulin antibodies was
performed on the sections. Dark brown staining in the monolayer corresponds to cilia axoneme b-tubulin. Arrows show loss of b-tubulin as the
ciliated cells transform into goblet cells. A representative photomicrograph has been shown (n=4); magnification 4006.
doi:10.1371/journal.pone.0014440.g003
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changes inthe airwayepithelia wereexamined. Asshown inFig.9A,
there wasa significant increaseinthe PAS positivecellsinthe airway
of RWE-challenged mice and absent in the lungs of mice treated
with fidarestat prior to RWE challenge. Similar to the inhibitor-
treated mice, AR-null mice challenged with RWE showed absence
of PAS positive cell in the airway (Fig. 9B). These results further
confirm that AR plays a significant role in the goblet cell metaplasia
and AR inhibition could prevent metaplasia in allergic asthma.
Discussion
Allergens are known to activate macrophages and Th2
lymphocytes which generate various cytokines and chemokines
that activate NADPH oxidase and generate excessive amounts of
ROS, a major contributor to allergic asthma [36–41]. We have
demonstrated earlier that ROS causes lipid peroxidation and the
reduced lipid-aldehyde-glutathione conjugates activate various
kinases which through the activation of transcription factors
induce expression of pro-inflammatory chemokines/cytokines that
increase ROS levels in autocrine and paracrine manner and
exacerbate asthma pathogenesis [28–31]. In addition, ROS
activate JAK-STAT pathway which in turn contributes to goblet
cell metaplasia, a major player in mucin production and airway
clogging [19,23,42,43]. Recently, Severgnini et al showed that
ROS regulates STAT activation in acute lung injury [44].
Similarly, Simon et al demonstrated that PDGF-dependent
activation of STAT in airway smooth muscle cells is redox-
dependent [45]. Further, treatment of antioxidants such as N-
acetyl-L-cysteine (NAC) prevented the activation of JAK-STAT
pathway indicating that the ROS plays a crucial role in this
pathway [43,45]. Activation of JAK-STAT pathway is involved in
the allergen-induced eosiniphilia, airway hyperresponsiveness and
mucus hypersecretion [19,23,24]. Indeed, we have demonstrated
that SAEC exposed to RWE or TNF-a generate excessive
amounts of ROS [26,46]. To further elucidate the role AR and
potential clinical utility of its inhibitor fidarestat, we examined
goblet cells metaplasia in exposed SAEC to IL-13, a Th2 cytokine
and mouse model of asthma.
We cultured SAEC 6 IL-13 and quantified ROS. A significant
(,2-fold) increase in the ROS levels in SAEC exposed to IL-13 and
prevention by AR inhibition (Fig. 2) suggests that AR inhibition
could play an anti-oxidative role. To investigate the effects of AR
inhibition on the goblet cell metaplasia, we cultured SAEC on ALI,
Figure 4. AR inhibition prevents IL-13-induced goblet cell metaplasia and expression of Muc5AC in airway epithelial monolayer. (A)
The well differentiated airway epithelial cells at ALI were incubated with IL-13 for 48 h without or with AR inhibitor, fidarestat. The monolayer was
fixed as described and immunohistochemistry using Muc5AC antibodies was performed on the sections. A representative photomicrograph has been
shown (n=4); magnification 4006.( B) The bar diagram shows number of Muc5AC positive cells per viewing area from 10 areas counted randomly
from each section under the microscope (n=4); *p,0.0005 vs Control; **p,0.004 vs IL-13. (C) The airway epithelial monolayer was incubated with IL-
13 submerged in basal medium for 48 h in the absence and presence of AR inhibitor, fidarestat. The culture medium was collected from the top
chamber and utilized for determination of Muc5AC by an ELISA, (n=4); *p,0.005 vs Control; **p,0.01 vs IL-13.
doi:10.1371/journal.pone.0014440.g004
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surface. Stimulation with IL-13 transformed majority of the cells
into mucus-filled goblet cells which lacked cilia. Further, when the
airway cells in monolayer were incubated withAR inhibitor prior to
IL-13 stimulation, metaplasia was prevented as the number of cells
with PAS staining and Muc5AC immuno-reactivity significantly
decreased and the cells in monolayer maintained ciliated morphol-
ogy. It has also been shown that Th2 cytokines-induced increase in
oxidativestressincreasednumberofmucus producing gobletcellsin
airway epithelium, which secrete excessive amounts of mucus,
especially Muc5AC [6–10]. Furthermore, activation of JAK-STAT
and MAPK pathways by allergen-induced increase in IL-13 in
allergic asthma has been demonstrated in goblet cell metaplasia
[25,47]. Our results that AR inhibition significantly prevented IL-
13-induced phosphorylation of JAK-1, ERK1/2 and STAT-6 in
airway epithelial cells suggest that AR could regulate the redox
signaling that is known to cause goblet cell metaplasia. SPDEF
orchestrate a transcriptional program for goblet cells differentiation,
and has been implicated in goblet cell metaplasia in response to
allergen or IL-13 challenge [20,21]. SPDEF transgenic mice
showed increased where as deletion of SPDEF gene in mice
preventedgoblet cell formationin the conducting airwayepithelium
subsequent to pulmonary allergen exposure [21,23]. Our results
suggest that prevention of IL-13-induced expression of SPDEF and
Muc5AC in airway epithelial cells by AR inhibition may contribute
to decreased metaplasia in AR inhibitor-treated cells (Fig. 5). These
observations thus indicate that AR inhibition could alter the redox
status of cells and prevent the activation of JAK-1, ERK1/2 and
STAT-6 and decrease the expression of mucin genes and their
regulators thereby prevent goblet cell metaplasia.
Prevention of goblet cell metaplasia by AR inhibition observed
in cultured airway epithelial cells was further confirmed by using a
Figure 5. AR inhibition prevents IL-13-induced expression of Mucin and SPDEF in airway epithelial cell monolayer. (A) The airway
epithelial cell monolayer at ALI was serum starved without or with fidarestat and incubated with IL-13 for 18 h. Total RNA was isolated and
subsequently RT-PCR was performed to assess the expression of Muc5AC and SPDEF. The bar diagrams show densitometric analysis of the
corresponding blots (n=4). *p,0.001 vs Control; **p,0.001 vs IL-13; (B) The monolayer of ciliated airway cells at ALI was treated with AR inhibitor for
24 h and subsequently incubated with IL-13 for 24 or 48 h. At the end of incubation, cell lysate was prepared and subjected to western blotting using
antibodies against Muc5AC, Muc5B, and SPDEF. The membranes were stripped and re-probed with antibodies against GAPDH to show the equal
loading of protein. A representative blot is shown (n=4). *p,0.0001 vs Control; **p,0.001 vs IL-13.
doi:10.1371/journal.pone.0014440.g005
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PAS positive goblet cells in the RWE-challenged mice lung was
significantly less in the mice treated with fidarestat. Further, to rule
out any nonspecific effect of the inhibitor, we used AR-knock out
mice in which RWE did not cause goblet cell metaplasia as
observed by the absence of PAS-stained goblet cells in airway
epithelium. These results further substantiate that AR inhibition or
deficiency could prevent the allergen-induced goblet cell metapla-
sia. In order to further understand how AR inhibition prevents
allergen-induced goblet cell metaplasia, we examined the effect of
AR inhibition on the levels of IL-13 expression and STAT-6
phosphorylation in the mice lungs. In the RWE-challenged and
fidarestat-treated mice there was significantly (80%) decreased IL-
13 expression compared to RWE-challenge without AR inhibitor.
The decrease in IL-13 correlated with decrease in STAT-6
phosphorylation and prevention of metaplasia by AR inhibition.
We have demonstrated it earlier that AR-catalyzed reduced
glutathione-lipid aldehydes such as GS-DHN via activation of
various protein kinases activate transcription factors which
transcribe inflammatory marker genes and inhibition of AR not
only prevents the transcription of inflammatory markers, it also
significantly blocks ROS generation thereby prevent further
amplification of this cycle [31,32]; Fig. 1). Although antioxidants
such as n-acetylcysteine (NAC), genistein and curcumin, caffeic
acid, alpha-lipoic acid, vitamin C and vitamin E have been
suggested earlier to attenuate airway inflammation in animal
models of asthma [48–55], none have been successfully developed
for clinical use in human. Since inflammatory cytokines and
subsequent generation of ROS are major contributors to asthma
pathogenesis including mucus hypersecretion, our results indicate
that AR inhibitors, such as fidarestat, could be developed to
prevent goblet cell metaplasia and mucus hypersecretion since this
inhibitor has already gone through phase III clinical trial for
diabetic neuropathy and found to be safe.
Figure 6. AR inhibition prevents IL-13-induced phosphorylation of JAK-1, ERK1/2 and STAT-6 in airway epithelial monolayer. The
ciliated monolayer of airway cells at ALI was treated with AR inhibitor for 24 h and stimulated with IL-13 for different time periods as indicated. At the
end of incubation, cells were lysed and cell lysate was subjected to western blotting using antibodies against phosphorylated and non-
phosphorylated JAK-1, ERK1/2 and STAT-6 to analyze the activation of these signaling proteins. A representative blot is shown (n=4). #p,0.001 vs
Control; *p,0.01 and **p,0.001 vs IL-13.
doi:10.1371/journal.pone.0014440.g006
Figure 7. AR inhibition prevents RWE-induced expression of IL-
13 in mouse lung. The mice were sensitized and challenged with PBS
or RWE, without or with AR inhibitor and 16 h later lungs were
harvested and total RNA was isolated (n=4). One microgram of total
RNA from each sample was transcribed into first-strand cDNA and
quantitative RT-PCR was conducted using IL-13 specific forward and
reverse primers. The levels of RNA for the target sequences were
determined by melting curve analysis. The values presented here are
fold-change over the control. (
**p,0.001). RWE, ragweed pollen extract;
ARI, aldose reductase inhibitor.
doi:10.1371/journal.pone.0014440.g007
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Ethics statement
All animal experiments were performed according to the
National Institutes of Health Guide for Care and Use of
Experimental Animals and approved by University of Texas
Medical Branch Animal Care and Use Committee (Animal
welfare assurance No. A3314-01).
Reagents
Small airway epithelial basal medium (SABM), and small airway
epithelial growth media (SAGM
TM) bulletkit; and Reagentpack
TM
containing Trypsin 0.025%/EDTA 0.01%, Trypsin neutralizing
solution and HEPES buffered-saline solution were purchased from
Lonza Walkersvillle Inc. (Walkersville, MD). Dulbecco’s modified
Eagle’s medium (DMEM)and phosphatebuffered saline (PBS) were
purchased from Gibco, Invitrogen (Grand Island, NY). AR
inhibitor, fidarestat, was a gift from Sanwa-Kayagu (South Korea).
Human recombinant IL-13 was from R & D systems (Minneapolis,
MN). Dimethyl sulfoxide (DMSO) was obtained from Fischer
scientific (Pittsburg, PA). Human mucin5AC ELISA kit was from
Cosmo Bio USA (Carlsbad, CA). Antibodies against STAT- 6,
phospho-STAT- 6, phospho-JAK1, JAK1, ERK1/2, phospho-
ERK1/2 were from Cell SignalingTech. (Danvers, MA)and mucin
5 subtypes A and C (Muc5AC), Muc5B, GAPDH and b-actin
antibodies were from Santa Cruz Biotechnology Inc. (Santa Cruz,
CA). Antibodies against SAM pointed domain-containing ETS
transcription factor (SPDEF) were purchaged from Abcam Inc.
(Cambridge MA). The polyethylene pteraphthalate transparent 12-
well Millicell cell culture insert with 1.0 mM pores were purchased
from Millipore Corp. (Billerica, MA). Rat tailcollagen type1 and all
trans-retinoic acid were from Sigma-Aldrich (Saint Louis, MO).
The reagents used in the Western blot analysis were obtained from
Sigma. All other reagents used were of analytical grade.
Cell culture
Primary human Small Airway Epithelial Cells (SAEC) obtained
from Lonza Walkersville, Inc. (Walkersville, MD) were normal
human SAEC harvested from distal airspace. The cells were
cultured and maintained according to the supplier’s instructions at
37uC in humidified atmosphere containing 95% air and 5% CO2
in small airway epithelial basal medium (SABM) supplemented
with 52 mg/ml bovine pituitary extract, 0.5 ng/ml human
recombinant epidermal growth factor (EGF), 0.5 mg/ml epineph-
rine, 1 mg/ml hydrocortisone, 10 mg/ml transferrin, 5 mg/ml
insulin, 0.1 ng/ml retinoic acid (RA), 6.5 ng/ml triiodothyronine,
50 mg/ml Gentamicin/Amphotericin-B (GA-1000), and 50 mg/ml
fatty acid-free bovine serum albumin (BSA).
Figure 8. AR inhibition prevents phosphorylation of STAT-6 in mouse lung epithelium. The mice were sensitized and challenged with PBS
or RWE, without or with AR inhibitor and 20 h later lungs were perfused and fixed with 4% paraformaldehyde, embedded in paraffin, and sectioned
to 5 mm. The sections were immunostained with p-STAT-6 specific antibodies using immunoflouroscence secondary antibodies (A) or DAB –based
HRP conjugated antibodies counterstained with hematoxylin and eosin (B). Photomicrographs were acquired by fluorescence or light microscopes. A
representative field for each group is shown (magnification: 2006). In (A) inset shows magnified view of the selected regions from representative
photomicrographs (n=4). RWE, ragweed pollen extract; ARI, aldose reductase inhibitor.
doi:10.1371/journal.pone.0014440.g008
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Approximately 5610
4 SAEC were seeded on 2-chambered
culture slides in triplicate or 10,000 SAEC per well were plated in
a 96-well plate. After they attached, cells were starved in basal
medium containing 0.1% serum without or with fidarestat
(10 mM) for overnight. Next day cells were washed with 16
HBSS buffer and incubated with 10 mMH 2DCF-DA at 37uC for
30 min, washed again to remove excess H2DCF-DA and treated
with IL-13 (25 ng/ml) for 1 h. At the end of incubation, cells were
washed twice with cold 16HBSS buffer. The cells on the culture
slide were mounted using floursave mounting medium with DAPI
after which photomicrographs were acquired using a fluorescence
microscope (Nikon). Fluorescence was determined using 485 nm
excitation and 538 nm emission wavelengths for cells in 96-well
plate and relative ROS production is expressed as mean
fluorescence intensity (MFI) (arbitrary units).
Air-liquid interface culture
For air-liquid interface (ALI) culture, SAEC were seeded at
8.5610
4 cells/12-mm-diameter PET transparent insert with
1.0 mM pores (12-well millicell culture insert; Millipore) and pre-
coated with rat tail collagen type-1 (Sigma-Aldrich). The cells were
grown submerged in the differentiation medium as described earlier
by Zhen et al (2007) [56]. The differentiation medium contained a
1:1 mixture of DMEM and small airway epithelial growth medium
supplemented as described above, except that gentamycin sulfate,
amphotericin B, and triiodothyronine were replaced with 1%
penicillin/streptomycin, and 50 nM all-trans retinoic acid. The
SAEC were maintained submerged for the first 7 days, after which
the apical medium was removed and an air–liquid interface culture
wasestablished.The cellsweremaintainedat ALIforthe remainder
of the culture period. Medium was refreshed every third day and
once in a week the apical surface of the cells was rinsed with PBS to
remove accumulated mucus and debris. Cells were maintained at
37uC in 95% air and 5% CO2 in a humidified incubator. The cells
on the ALI were pre-treated with AR inhibitor, fidarestat (10 mM),
for over-night from the basal side in differentiation medium without
EGF beginning day 11 after establishment of ALI and stimulated
with IL-13 by addition of recombinant human IL-13 (25 ng/ml) to
the medium for varying time periods as indicated.
Cell fixation and immunocytochemistry
After the completion of incubation with IL-13, the apical
surface of the cells was rinsed with PBS and cells were fixed in
10% z-fix, aqueous buffered-zinc formalin (Anatech Ltd; Battle
Creek, MI), for 24 h at 4uC and embedded in paraffin. The 5 mM
thin sections of the epithelial cell monolayer on the membrane
insert were stained with H&E and periodic acid Schiff (PAS)-stain.
The stained sections were analyzed and representative fields were
photographed using a Photometrix CoolSNAP Fx camera
mounted on a NIKON Eclipse TE 200 UV microscope.
Antibodies against b-tubulin and Muc5AC (Santa Cruz
Biotechnology, Santa Cruz, CA) and matched control IgG were
used for immunocytochemistry. Antibodies were detected using
the Vector LSAB kit (Vector Laboratories, Burlingame, CA) as
suggested by the manufacturer.
Figure 9. Inhibition or deficiency of AR prevents RWE-induced goblet cell metaplasia in mice lungs. RWE-sensitized normal and AR-null
mice were challengedwith RWE and72 h later the lungs were harvestedfrom mice treated without or with ARinhibitor(A) or AR-null mice (B), perfused
and fixed with 4% paraformaldehyde and embedded in paraffin. The sections were stained with PAS stain and observed under light microscope and
photomicrographs were acquired. A representative photomicrograph from each group is shown (n=4). Magnification 2006(A); 4006(B).
doi:10.1371/journal.pone.0014440.g009
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Total RNA was isolated from differentiated SAEC treated with
IL-13 with or without AR inhibitor by using RNeasy kit (Qiagen) as
per supplier’s instructions. Aliquots of RNA (1.0 mg) isolated from
each sample were reverse-transcribed with Omniscript and Sensi-
script reverse transcriptase one-step RT-PCR system with HotStar
Taq DNApolymerase (Qiagen) at 55uC for 30 min followed by
PCR amplification. The oligonucleotide primer sequences were as
follows: Muc5AC: 59-TCCGGCCTCATCTTCTCC-39 (sense)
and 59-ACTTGGGCACTGGTGCTG-39 (Antisense); SPDEF:
59-CGAAGTGCTCAAGGACATCGAG-39 (sense) and 59-CGG-
TATTGGTGCTCTGTCCACA-39 (anti-sense) and GAPDH: 59-
GACCCCTTCATTGACCTCAAC-39 (sense) and 59-CATAC-
CAGGAAATGAGCTTG- 39 (antisense). RT-PCR reaction was
carried out in a PCR Sprint thermal cycler (Thermo electron
corporation, Milford, MA) under the following conditions: initial
denaturation at 95uC for 15 min followed by 35 cycles at 94uC for
1 min, 60uC for 1 min, 72uC for 1 min, followed by 72uC for
10 min for final extension. The RT-PCR products were subjected
to electrophoresis on a 1.5% agarose-1X TAE gels containing
0.5 mg/ml ethidium bromide. The densitometry analysis of the gel
was performed using NIH image analysis software.
Western blot analysis
Subsequent to incubations, the cells were washed with cold PBS
and lysed in RIPA lysis buffer. The cell lysates were pooled and
cleared by centrifugation. Protein levels were determined using
Bradford reagent (Biorad, Hercules, CA). Forty micrograms of
protein were mixed with sample buffer and resolved on 10% SDS-
PAGE. After electrophoresis, the proteins were electro transferred
to a nitrocellulose membrane, blocked with 5% nonfat milk in
TBST, and probed with antibodies against phospho-ERK1/2,
ERK1/2, phospho-STAT-6, STAT-6, Muc5AC, Muc5B, and
SPDEF for overnight at 4uC. The blots were then washed, exposed
to HRP-conjugated secondary antibodies (1:5,000 dilution) for
1 h, and the antigen-antibody complex was detected by enhanced
chemiluminescence (Amersham Pharmacia Biotech, Piscataway,
NJ, USA). The membranes were stripped and reprobed with
antibodies against GAPDH to depict loading control. Densitom-
etry was performed by biospectrum 410 image system from Ultra
Violate Products Ltd. (Cambridge, UK).
Muc5AC ELISA
Muc5AC levels in the culture medium were assessed by ELISA
using commercially available human anti-Muc5AC ELISA
essentially as described by the manufacturer (Cosmo Bio USA;
Carlsbad, CA).
Sensitization and challenge of animals
Wild type C57BL/6 and Balb/cJ mice were purchased from
Harlan Sprague-Dawley (San Diego, CA, USA) and AR null mice
on C57BL/6 background were bread by us at Animal resource
center, UTMB, Galveston, TX. Six-eight weeks old female mice
were sensitized with RWE as previously described [35]. Briefly,
mice were sensitized with two intraperitoneal administrations of
100 ml of endotoxin-free RWE (150 mg) combined with Alum
adjuvant (1 mg) in a 3:1 ratio (v/v), on days 0 and 4. On day 11,
mice (n=6) were challenged intranasally with RWE (100 mg). A
parallel group of mice received fidarestat (7 mg/kg body wt/day)
in drinking water from one day before the challenge. Control
groups of mice were challenged with equivalent volumes of PBS.
The animals were euthanized at different time points as
mentioned, with ketamine (135 mg/kg body wt) and xylazine
(15 mg/kg body wt), the lungs were perfused and fixed with 4%
paraformaldehyde, embedded in paraffin, and sectioned to 5 mm.
Lung sections were stained with PAS and the representative fields
were observed and photographed with a Photometrix CoolSNAP
Fx camera mounted on a NIKON Eclipse TE 200 UV
microscope.
Determination of IL-13 in mice lungs
The mice lungs were harvested 16 h after RWE-challenge and
total RNA was isolated. From each sample, one microgram of total
RNA was transcribed into first-strand cDNA and quantitative RT-
PCR was conducted using IL-13 specific forward and reverse
primers 59AGACCAGACTCCCCTGTGCA, 39TGGGTCCT-
GTAGATGGCATTG; GAPDH specific primers (59TGTGTCC-
GTCGTGGATCTGA, 39CCTGCTTCACCACCTTCTTGAT)
were used as house keeping gene (HKG) control. Data were
collected and analyzed by ABI 7000 System equipment and
software (Applied Biosystems, Foster City, CA). To assess
expression levels, delta-delta Ct method (DDCT) was used. Values
of expression in fold increase (ratio of control) were calculated
using the formula for relative expression by the method of Delta
DeltaCT (DDCT): F=2
2DDC. F=fold change (ratio of control),
2DDCT=( C T Target-CTHKG)
Time x 2 (CT Target-CT HKG)
Time 0.
Time x is any time point. Time 0 represents 16expression of the
target gene normalized to a HGK.
Detection of STAT-6 phosphorylation in mouse lungs
Approximately 20 h after RWE-challenge, mice were killed and
lungs were perfused and fixed with 4% paraformaldehyde,
embedded in paraffin, and 5 mm sections were obtained. The
sections were immunostained with p-STAT-6 specific primary
antibodies followed by probing with either FITC labeled
secondary antibodies and mounted with frourosave medium with
DAPI or DAB –based HRP-conjugated antibodies from Vector
LSAB kit (Vector Laboratories, Burlingame, CA) and counter-
stained with hematoxylin and eosin. Photomicrographs were
acquired by Photometrix CoolSNAP Fx camera mounted on a
NIKON Eclipse TE 200 UV microscope using fluorescence or
bright-field microscopy, respectively.
Statistics
Data presented as mean 6 SE and statistical significance was
determined by unpaired Student’s t test using graph pad prism
software (GraphPad Software, Inc. La Jolla, CA). The value of
P,0.05 was considered as statistically significant.
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